Impact of prior (neo)adjuvant trastuzumab (NAT) exposure on the efficacy of HER2-targeted therapy for metastatic breast cancer

Kanjanapan, Y; Lok, SW; Gibbs, P; De Boer, R; Yeo, B; Greenberg, S; Barnett, F; Knott, L; Richardson, G; Wong, R; Nottage, M; Collins, Ian; Torres, J; Lombard, J; Johns, J; Harold, M; Malik, L

Impact of prior (neo)adjuvant trastuzumab (NAT) exposure on the efficacy of HER2-targeted therapy for metastatic breast cancer

journal contribution

posted on 2024-06-03, 22:17 authored by Y Kanjanapan, SW Lok, P Gibbs, R De Boer, B Yeo, S Greenberg, F Barnett, L Knott, G Richardson, R Wong, M Nottage, Ian CollinsIan Collins, J Torres, J Lombard, J Johns, M Harold, L Malik

Impact of prior (neo)adjuvant trastuzumab (NAT) exposure on the efficacy of HER2-targeted therapy for metastatic breast cancer

History

Journal

Breast cancer research and treatment

Volume

184

Pagination

87-95

Location

Cham, Switzerland

Publisher DOI

https://doi.org/10.1007/s10549-020-05825-w

ISSN

0167-6806

eISSN

1573-7217

Language

English

Author URL

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000558149400002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a045e4b2bb1f2b747c68c720ec8913b7

Publication classification

C1 Refereed article in a scholarly journal

Issue

1

Publisher

Springer

Usage metrics

Keywords

Science & Technology Life Sciences & Biomedicine Oncology Trastuzumab Pertuzumab Metastatic breast cancer De novo 3211 Oncology and carcinogenesis

Impact of prior (neo)adjuvant trastuzumab (NAT) exposure on the efficacy of HER2-targeted therapy for metastatic breast cancer

History

Journal

Volume

Pagination

Location

Publisher DOI

ISSN

eISSN

Language

Author URL

Publication classification

Issue

Publisher

Usage metrics

Categories

Keywords

Licence

Exports